Skip to main content

Indian Journal of Hematology and Blood Transfusion

Ausgabe 1/2021

Inhalt (34 Artikel)

Zur Zeit gratis COVID-19 Consensus Document

Indian Society of Hematology and Blood Transfusion (ISHBT) Consensus Document on Hematological Practice During COVID-19 Pandemic

Rakhee Kar, Tuphan Kanti Dolai, Prakash Singh Shekhawat, Pankaj Malhotra, Avinash Singh, Rahul Naithani, Prakas Kumar Mandal, Prasanth Ganesan, Prabhu Manivannan, Debdatta Basu, Alok Srivastava, Reena Das, Maitreyee Bhattacharya, Manoranjan Mahapatra, Rishi Dhawan, Arihant Jain, Chandni Bhandary, Hara Prasad Pati, Tathagata Chatterjee, Vijai Tilak, Sarmila Chandra, Shrimati Dharampal Shetty, Rabindra Kumar Jena

Original Article

Impact of ABCB1 Gene (C3435T/A2677G) Polymorphic Sequence Variations on the Outcome of Patients with Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Kashmiri Population: A Case–Control Study

Shahid M. Baba, Arshad A. Pandith, Zafar A. Shah, Sajad A. Geelani, Mohammad Muzaffar Mir, Javid Rasool Bhat, Gul Mohammad Bhat

Open Access Original Article

Sequential Treatment of Arsenic Trioxide Followed by All Trans Retinoic Acid with Anthracyclines has Excellent Long-Term Cure in Acute Promyelocytic Leukemia

Santhosh Kumar Devadas, Hasmukh Jain, Bausaheb Bagal, Manju Sengar, Uma Dangi, Navin Khattry, Pratibha Amre, Nikhil Patkar, P. G. Subramaniam, Reena Nair, Hari Menon

Original Article

Prognostic Impact of Serum Growth Differentiation Factor 15 Level in Acute Myeloid Leukemia Patients

Hany Mohamed Hegab, Amro Mohamed Sedky El-Ghammaz, Mostafa Kamal El-Razzaz, Reham Ali Ali Helal

Original Article

Clinical and Laboratory Profiles of 17 Cases of Chronic Granulomatous Disease in North India

Sabina Langer, Nita Radhakrishnan, Soma Pradhan, Jasmita Das, Amrita Saraf, Jyoti Kotwal

Original Article

Comparison of Clinical Features Between Primary and Secondary Breast Diffuse Large B Cell Lymphoma: A Yokohama Cooperative Study Group for Hematology Multicenter Retrospective Study

Hiroyuki Takahashi, Rika Sakai, Takayuki Sakuma, Ayako Matsumura, Kazuho Miyashita, Yoshimi Ishii, Yuki Nakajima, Ayumi Numata, Yukako Hattori, Takuya Miyazaki, Chizuko Hashimoto, Hideyuki Koharazawa, Sachiya Takemura, Jun Taguchi, Katsumichi Fujimaki, Hiroyuki Fujita, Hideaki Nakajima

Original Article

Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy

Zehra Narli Ozdemir, Guldane Cengiz Seval, Ugur Sahin, Atilla Uslu, Mehmet Gunduz, Sinem Civriz Bozdag, Selami Kocak Toprak, Meltem Kurt Yuksel, Pervin Topcuoglu, Isinsu Kuzu, Muhit Ozcan, Gunhan Gurman, Osman Ilhan

Original Article

The Association of Pre-diagnostic Inflammatory Markers and Adipokines and the Risk of Non-Hodgkin Lymphoma Development in Egypt

Doaa Mohamed El Demerdash, Nehad Mohamed Tawfik, Raghda Elazab, Maha Hamdi El Sissy

Original Article

Conditioning Regimens for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Stem Cell Transplantation: BEAM Versus High Dose ICE

Ahmet Kursad Gunes, Simten Dagdas, Funda Ceran, Mehmet Ali Ucar, Mesude Falay, Cenk Sunu, Meltem Ayli, Nurullah Zengin, Gulsum Ozet

Original Article

The Treatment Effect of Protamine on Severe Coagulopathy in Epstein–Barr Virus-Associated Hemophagocytic Lymphohistiocytosis: Case Reports and Literature Review

Qian Zhang, CunLiang Yan, Lei Xu, Wenyue Xie, JinMeng Li, Wenli Zhang, HaiChan Xu, HongYu Zhang

Original Article

Inherited Bleeding Disorders in Pediatric Patients; experience of the national referral center in Iraq

Abbas Hashim Abdulsalam, Nidhal Karim Al-Rahal, Yusra Ghiath

Original Article

Intravenous Fat Emulsion Does Not Significantly Alter Clotting Markers in Dabigatran-Treated Blood

Samuel J. Stellpflug, Michael E. Bond, Keith D. Henry, Kristin M. Engebretsen, Nicole D. Zantek

Original Article

A Comparative Study of Bone Marrow Squash and Wedge Aspiration Smears

Neeti Arora Ahluwalia, Naveen Kakkar, Kanwardeep Singh Kwatra

Original Article

Clinical Profile and Severity of Hemolysis in Adult Patients of Primary Autoimmune Hemolytic Anemia and Their Response to Steroid: A Prospective Cohort Study from Single Institution

Gopal Krushna Ray, Debasish Mishra, Rabindra Kumar Jena, Smita Mahapatra, Sabita Palai, Ansuman Abhishek Parida

Original Article

RBC Inventory-Management System Based on XGBoost Model

Xiaolin Sun, Zhenhua Xu, Yannan Feng, Qingqing Yang, Yan Xie, Deqing Wang, Yang Yu

Original Article

Plateletpheresis in the Era of Automation: Optimizing Donor Safety and Product Quality Using Modern Apheresis Instruments

Sudipta Sekhar Das, Subrata Sen, R. U. Zaman, Rathindra Nath Biswas

Original Article

Changes in Complement Levels and Activity of Red Blood Cells, Fresh Frozen Plasma, and Platelet Concentrates During Storage

Xiaomin Liu, Ruoshuai Cui, Yingwei Song, Yang Liu, Leiying Zhang, Shufang Wang, Hongfei Zhang, Jinghua Sun, Ping Di, Yang Yu, Deqing Wang

Short Communication

Non Malignant Lymphoproliferative Disorders in Children: A Case Series

Meena Sivasankaran, Rishab Bharadwaj, Somu Sivabalan, Ravikumar Thangadorai, Vimal Kumar, Deenadayalan Munirathnam

Short Communication

Sitosterolemia: Four Cases of an Uncommon Cause of Hemolytic Anemia (Mediterranean Stomatocytosis with Macrothrombocytopenia)

Sudhamsh Reddy Desai, Anu Korula, Uday Prakash Kulkarni, Aswathy Ashok Menon, Shaji V. Ramachandran, Eunice Sindhuvi, Arun Jose Nellickal, Sukesh C. Nair, Biju George

Short Communication

A Pilot Study on Probing of Imatinib Induced Platelet Dysfunction in Patients with Chronic Myeloid Leukemia-Chronic Phase and Absence of Associated Bleeding Manifestation: Trying to Solve an Enigma

Rajib De, Ranjini Chowdhury, Tuphan Kanti Dolai, Biswajit Bhar, Mohammad Mirazul Islam, Prantar Chakrabarty, Suryyani Deb

Correspondence

Does Development of Plasmacytosis have a Role in Spontaneous Remission of Acute Myeloid Leukemia?

Nishant Jindal, Ram Nampoothiri, Sweta Rajpal, Sreejesh Sreedharanunni, Neelam Varma, Pankaj Malhotra

Correspondence

Safety and Efficacy of Bendamustine-Rituximab in Treatment Naïve Symptomatic Follicular Lymphoma: An Institutional Analysis

Ajay Gogia, Sudhir Kumar, Lalit Kumar, Atul Sharma, Soumya Mallick

Correspondence

A Case of Severe Hemolytic Disease of the Newborn Caused by Anti-Dia and SLC4A1 Gene Analysis in the Family

Ni Wang, Li Zhang, Shi-Hang Zhou, Wei-Jian Yu, Shi-Chuan Cai, Ming Liu

Correspondence

Primary Mediastinal B Cell Lymphoma: A Limited Institutional Experience with Uniform DAEPOCH-R Protocol

Ajay Gogia, Sudhir Kumar, Santosh Kumar Chellapurum, Ahitagni Biswas, Soumya Mallick

Correspondence

Orbital Rhabdomyosarcoma Infiltrating the Bone Marrow: A Potential Mimic of a Haematopoietic Neoplasm

Praveen Sharma, Sonal Singla, Pulkit Rastogi, Sandeep Bansal, Jasmina Ahluwalia

Zur Zeit gratis COVID-19 Correspondence

COVID-19 in Adult Patients with Hematological Disease: Analysis of Clinical Characteristics and Outcomes

R. Lattenist, H. Yildiz, J. De Greef, S. Bailly, J.C. Yombi

Correspondence

The Journey of Primary Myelofibrosis to Splenic Marginal Zone Lymphoma on the Wheels of Ruxolitinib

Jasmita Dass, Sabina Langer, Jyoti Kotwal, Nitin Gupta

Images

Metastatic Angiosarcoma of Bone Marrow Mimicking a Pleomorphic Myeloma

Shruti Mishra, Ashutosh Panigrahi, Amit Kumar Adhya

Images

Secondary Hemophagocytic Lymphohistiocytosis in an Infant with Wolman Disease

Sandip Bartakke, Amit Nisal, Vibha Bafna, Aashna Valecha

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.